Your browser doesn't support javascript.
loading
First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study.
Wu, Yahua; Du, Bin; Lv, Chengliu; Ji, Xiaohui; Lan, Yanqin; Yao, Na; Zhu, Yingjiao; Lai, Jinhuo.
Afiliação
  • Wu Y; Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Du B; Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Lv C; Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Ji X; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China.
  • Lan Y; Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Yao N; Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Zhu Y; Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Lai J; Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Ann Med ; 55(2): 2243967, 2023.
Article em En | MEDLINE | ID: mdl-37557185
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article